{
    "success": true,
    "data": {
        "ucits": true,
        "type": "ETF",
        "replication_method": "physical",
        "leverage": false,
        "derivatives": false,
        "swaps": false,
        "inverse": false,
        "complex_factors": "Potential counterparty risk arising from the use of derivatives for efficient portfolio management (EPM) and from securities lending, which some regulators may interpret more strictly despite physical replication and UCITS presumption.",
        "classification": "non-complex",
        "supporting_data": "The asset is explicitly identified as a UCITS ETF, which establishes a baseline presumption of non-complexity under MiFID II (MiFID II Rules, Section 1; CESR/09-295, Section 3, Para 69 & Annex I). The Sub-Fund employs 'Direct Replication, mainly by making direct investments in transferable securities', which is physical replication, a key characteristic of non-complex ETFs (MiFID II Rules, Section 3). The use of derivatives is stated to be 'in order to deal with inflows and outflows and also if it allows a better exposition to an Index constituent'. This falls under efficient portfolio management (EPM) rather than being integral to the core replication strategy (MiFID II Rules, Section 2). Per the provided rules, if derivatives are used for managing risk rather than as an inherent element of the strategy, 'derivatives' should be marked false. The KID does not explicitly mention 'swaps' being used; it refers generally to 'derivatives'. Given the specific instruction 'If any element of ... any Swap usage is identified then the 'classification' must be 'complex'', and the absence of explicit 'swap' identification for any purpose (especially not for replication, which is physical), the 'swaps' field is marked false. The fund does not mention significant leverage (beyond standard UCITS temporary borrowing limits), nor does it have capital protection features involving complex structures. The underlying index is transparent with publicly available methodology. While counterparty risk from EPM derivatives and securities lending is noted (and is a risk factor), the ESMA guidance (CESR/09-295, Annex I, point 3) explicitly states for UCITS that 'the fact that an undertaking invests in derivatives will not automatically make it 'complex' for these purposes', reinforcing the non-complex classification for UCITS using derivatives for EPM within a physical replication strategy."
    }
}